Xagenic Looks To Launch Point-of-Care Molecular Dx Platform Targeting Infectious Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
The start-up has created the Xagenic X1 platform to run molecular diagnostic tests in a physician's office in about 20 minutes instead of sending samples out to a lab.